Cargando…

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

Background and aims: Non-alcoholic steatohepatitis (NASH) is a life-threatening stage of non-alcoholic fatty liver disease (NAFLD) for which no drugs have been approved. We have previously shown that human-derived hepatic in vitro models can be used to mimic key cellular mechanisms involved in the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeckmans, Joost, Gatzios, Alexandra, Heymans, Anja, Rombaut, Matthias, Rogiers, Vera, De Kock, Joery, Vanhaecke, Tamara, Rodrigues, Robim M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909190/ https://www.ncbi.nlm.nih.gov/pubmed/35269515 http://dx.doi.org/10.3390/cells11050893

Ejemplares similares

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
por: Gatzios, Alexandra, et al.
Publicado: (2022)

Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor
por: Boeckmans, Joost, et al.
Publicado: (2019)

Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH
por: Boeckmans, Joost, et al.
Publicado: (2020)

Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
por: Boeckmans, Joost, et al.
Publicado: (2019)

Infections at the nexus of metabolic-associated fatty liver disease
por: Boeckmans, Joost, et al.
Publicado: (2021)

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
por: Boeckmans, Joost, et al.
Publicado: (2020)

Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples
por: Rodrigues, Robim M., et al.
Publicado: (2016)

Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5’ Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile Analysis
por: Bolleyn, Jennifer, et al.
Publicado: (2020)

In Vitro Differentiation of Embryonic and Adult Stem Cells into Hepatocytes: State of the Art
por: Snykers, Sarah, et al.
Publicado: (2009)

Current Status of Human Adipose–Derived Stem Cells: Differentiation into Hepatocyte-Like Cells
por: Al Battah, Feras, et al.
Publicado: (2011)

Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells
por: De Kock, Joery, et al.
Publicado: (2020)

Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging
por: Merimi, Makram, et al.
Publicado: (2021)

The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells
por: Buyl, Karolien, et al.
Publicado: (2020)

Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
por: Tsai, Hung-Cheng, et al.
Publicado: (2019)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
por: Lequeue, Sien, et al.
Publicado: (2022)

Development and characterization of a new human hepatic cell line
por: Ramboer, Eva, et al.
Publicado: (2015)

Effects of Trichostatin A on drug uptake transporters in primary rat hepatocyte cultures
por: Ramboer, Eva, et al.
Publicado: (2015)

Exposure of HepaRG Cells to Sodium Saccharin Underpins the Importance of Including Non-Hepatotoxic Compounds When Investigating Toxicological Modes of Action Using Metabolomics
por: Cuykx, Matthias, et al.
Publicado: (2019)

Applicability of the DPRA on mixture testing: challenges and opportunities
por: Marcelis, Quinten, et al.
Publicado: (2023)

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
por: van den Hoek, Anita M., et al.
Publicado: (2021)

A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death
por: Briand, François, et al.
Publicado: (2020)

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
por: Neuckermans, Jessie, et al.
Publicado: (2023)

Publisher Correction: Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells
por: Fraire, Juan C., et al.
Publicado: (2022)

Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells
por: Fraire, Juan C., et al.
Publicado: (2022)

Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019
por: Gustafson, Emma, et al.
Publicado: (2020)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology
por: Joanna, Fraczek, et al.
Publicado: (2009)

Inflammation Differentially Modulates the Biological Features of Adult Derived Human Liver Stem/Progenitor Cells
por: El-Kehdy, Hoda, et al.
Publicado: (2020)

Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
por: Kamata, Shotaro, et al.
Publicado: (2023)

Upregulation of sodium taurocholate cotransporter polypeptide during hepatogenic differentiation of umbilical cord matrix mesenchymal stem cells facilitates hepatitis B entry
por: Sargiacomo, Camillo, et al.
Publicado: (2017)

Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?
por: Doktorova, T. Y., et al.
Publicado: (2014)

Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
por: Colemonts-Vroninks, Haaike, et al.
Publicado: (2020)

Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow
por: Snykers, Sarah, et al.
Publicado: (2007)

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
por: Ji, Longshan, et al.
Publicado: (2022)

Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response
por: Peters, Stephan J. A. C., et al.
Publicado: (2010)

The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
por: Soresi, Maurizio, et al.
Publicado: (2020)

Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration
por: Pedersen, Julie S., et al.
Publicado: (2022)

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
por: Xia, Yi, et al.
Publicado: (2022)

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lqh5djk2efd9gclaetbkngulnc